Top

LATEST PUBLICATIONS



New metric predicts burden of participating in trials

May 9, 2024

To try to tackle that problem, data analytics specialist Phesi has developed software that can look at the design of a study, gauge how burdensome it will be, and recommend changes to the protocol to lighten the load on patients […]


Novartis’ Lutathera receives FDA approval to treat neuroendocrine tumours in paediatric patients

April 25, 2024

Via: PMLiVE

Patients eligible for the therapy will be aged 12 years and older and have somatostatin receptor (SSTR)-positive gastroenteropancreatic NETs, including foregut, midgut and hindgut NETs. The FDA’s decision was supported by positive results from the NETTER-P trial, which evaluated Lutathera […]


The Path to a Better Tuberculosis Vaccine Runs Through Montana

April 18, 2024

Category: Industry, Vaccines

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains […]